December 2022 | VOL. 19, ED. 6
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Pharmacotherapy: “April”, opioid agonist treatment Integrated Care: Tess Mungovan, QuIHN Residential Rehab: Catherine Coles, CAAPS Q&A: “Zoe”, living experience Latest Issues View All Issues
November 2022 | VOL. 19, ED. 5
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Cloud of Confusion: vaping as harm minimisation Prison & Performance Drugs, Disability & the NDIS Q&A Dr Mary Ellen Harrod Latest Issues View All Issues
October 2022 | VOL. 19, ED. 4
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Injecting in NSP-Adjacent Public Facilities CanTEST: Early Findings from Australia’s Flagship Drug-Checking Service Q&A with Professor James Ward Nitrous Oxide | Are ‘nangs’ cause for concern? Latest Issues View All Issues
September 2022 | VOL. 19, ED. 3
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Removing the Barriers to Access Q&A with Kirsten Horsburgh Australia: Hep C-Free by 2030? Interrogating the Gender Gap in Overdose Deaths Latest Issues View All Issues
August 2022 | VOL. 19, ED. 2
– The waiting game: Australia’s capacity crunch for residential treatment
– Mick Palmer Q&A
– The World is Getting Creative for IOAD 2022!
– Co-occurring mental health and substance use crises: from ‘passing the buck’ to integrated care
July 2022 | VOL. 19, ED. 1
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue NSP Workers Report Growing Trend of Problematic Steroid Use Stories from the Frontline: Jo Beckett, Youth Projects The state of medicinal cannabis in Australia today Q&A Marguerite White Latest Issues View All Issues
June 2022 | VOL. 18, ED. 10
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Drugs and the 2022 Federal Election Hope on the Horizon: Trials target pharmacotherapy for methamphetamine use New Drug Price Regime Raises Questions Q&A Cheryl Delalande Latest Issues View All Issues
May 2022 | VOL. 18, ED. 9
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Standover tactics: how treatment can be hijacked by coercive control Standing firm: pharmacotherapy use stable as clients age Budget benefit: harm reduction affirmed in federal funding plan Q&A Donna Garcia Latest Issues View All Issues
April 2022 | VOL. 18, ED. 8
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Kick-start for ket: how ketamine emerged as Australia’s lockdown means of escape Highs and lows: how COVID has affected Australia’s use of drugs Soldiering on: in Ukraine, harm reductionists remain resolute against all odds Q&A with Fiona Patten: What we’re doing […]
March 2022 | VOL. 18, ED. 7
The Bulletin Home All Issues Feedback Subscribe Colour PDF Greyscale PDF In this issue Fentanyl fears: Australia alert to heightened overdose threat Naloxone’s Big 3: three lives a day saved by take-home supply Please explain: how NSP workers talk about their work and manage listeners’ reactions Q&A Senator Vernon White: ‘Almost any solution’s better than […]